TIPS and hepatic encephalopathy

Seminars in Liver Disease

Volumn 16, Issue 3, 1996, Pages 315-320

  Pomier Layrargues, Gilles ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATIC ENCEPHALOPATHY; HUMAN; INCIDENCE; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; PARACENTESIS; PORTAL HYPERTENSION; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; REVIEW; SCLEROTHERAPY; SHUNTING; STENT;

EID: 0030448987     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1007243     Document Type: Review

References (41)

1. Hahn M, Massenn O, Nancki M, Pawlow J: Die Eck's fistelswishen der unteren hohlvane und der pfortader und ihre fagen fur den ortganismmis. Arch Exp Pathol Pharmacol 32:161-210, 1893.
2. Victor M, Adams RD, Cole M: The acquired (non-Wilsonian) type of chronic hepatocerebral degeneration. Medicine (Baltimore) 44:345-96, 1965.
3. Franco D, Smajda C: Prevention of recurrent variceal bleeding: surgical procedures. Clin Gastroenterol 14:233-57, 1985.
4. Sarfeh IJ, Rypins EB, Mason GR: A systematic appraisal of portocaval H-graft diameters. Clinical and hemodynamic perspectives. Ann Surg 204:356-63, 1986.
5. Johansen K: Prospective comparison of partial versus total portal decompression for bleeding esophageal varices. Surg Gynecol Obstet 175:528-34, 1992.
6. Henderson JM: Variceal bleeding: which shunt? Gasnoenterology 91:1021-3, 1986.
7. Sarfeh IJ, Rypins EB: Partial versus total portacaval shunt in alcoholic cirrhosis: results of a prospective, randomized clinical trial. Ann Surg 219:353-61, 1994.
8. Infante-Rivard C, Esnaola S, Villeneuve JP: Role of endoscopic variceal sclerotherapy in the long-term management of variceal bleeding: a metaanalysis. Gastroenteroiogy 96:1087-92, 1989.
9. Villeneuve JP, Infante-Rivard C: Prevention of variceal rebleeding by propranolol: should it work? Does it work? Hepatology 7:1386-1388, 1987.
10. Richter GM, Noldge G, Palmaz JC, Rössle M: The transjugular intrahepatic stent shunt (TIPSS): results of a pilot study. Cardiovasc Intervent Radiol 13:200-7, 1990.
11. Conn HO: Transjugular intrahepatic portal systemic shunts: the state of the art. Hepatology 17:148-58, 1993.
12. Coldwell DH, Ring EJ, Rees CR, et al: Multicenter investigation of the role of transjugular intrahepatic portosystemic shunt in management of portal hypertension. Radiology 196:335-40, 1995.
13. Dagenais M, Pomier-Layrargues G, Dufresne MP, et al: Experience with the transjugular intrahepatic portacaval shunt. (In french) Ann Chir 48:671-8, 1994.
14. Laberge JM, Ring EJ, Gordon RL, et al: Creation of transjugular intrahepatic portosystemic shunts with Wallstent endoprosthesis; results in 100 patients. Radiology 187:413-20, 1993.
15. MacCormick PA, Dick R, Burroughs AK: The transjugular intrahepatic portosystemic shunt (TIPS) in the treatment of portal hypertension. Aliment Pharmacol Ther 8:273-82, 1994.
16. Martin M, Zajko AB, Orons PD, et al: Transjugular intrahepatic portosystemic shunt in the management of variceal bleeding: indications and clinical results. Surgery 114:719-27, 1993.
17. Rössle MR, Haag K, Ochs A, et al: The transjugular intrahepatic portosystemic stent-shunt procedures for vanceal bleeding. N Engl J Med 330:165-71, 1994.
18. Sanyal AJ, Schiffman ML: Transjugular intrahepatic portosystemic shunts. Curr Opm Gastroenterol 11:228-32, 1995.
19. Simpson KJ, Chalmers N, Redhead DW, et al: Transjugular intrahepatic portosystemic stent shunting for control of acute and recurrent upper gastro-intestinal haemorrhage related to portal hypertension. Gut 34:968-73, 1993.
20. Lotterer E, Moosmüller A, Wengert A, et al: Effects of transjugular intrahepatic portal systemic shunt (TIPS) on liver function in patients with alcoholic cirrhosis. Hepatology 20:108A, 1994.
21. Alam I, Bacchetti P, MacNally C, Somberg K: Liver function after transjugular intrahepatic portosystemic shunt (TIPS): short-term effects and prognosis. Hepatology 22:254A, 1995.
22. Lafortune M, Martinet JP, Denys A, et al: Short- and long-term hemodynamic effects of transjugular intrahepatic portosystemic shunts: a Doppler/manometric correlation study. Am J Roentgenol 164:997-1002, 1995.
23. Alvarez W, Piera C, Bandi JC, et al: Quantification of the extent of portal systemic shunting before and after TIPS: relationship with portal systemic encephalopathy. Abstract. Hepatology 22:296A, 1995.
24. Reynolds TB: Promises! Promises! Hemodynamics and portal systemic shunt. New Engl J Med 290:1484-5, 1974.
25. Sanyal A, Freedman AM, Schiffman ML, et al: Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study. Hepatology 20:46-55, 1994.
26. Somberg KA, Riegler JL, Laberge JM, et al: Hepatic encephalopathy after transjugular intrahepatic portosystemic shunts: incidence and risk factors. Am J Gastroenterol 90:549-55, 1995.
27. Ochs A, Rössle M, Haag K, et al: The transjugular intrahepatic portosy stemic stent-shunt procedure for refractory ascites. N Engl J Med 332:1192-7, 1995.
28. Jalan RJ, Elton RA, Redhead DN, et al: Analysis of prognostic variables in the prediction of mortality, vanceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal hemorrhage. J Hepatol 23:123-8, 1995.
29. Pomier-Layrargues G, Huet PM. Infante-Rivard C, et al: Prognostic value of indocyanine green and lidocaine kinetics for survival and chronic hepatic encephalopathy in cirrhotic patients following elective end-to-side portacaval shunt. Hepatology 8:1506-10, 1988.
30. Planas R, Gomez-Viera MC, Cabre E, et al: Prognostic factors of hepatic encephalopathy after portacaval anastomosis: a multivariate analysis in 50 patients. Am J Gastroenterol 87:1792-6, 1992.
31. Harell EF, Lee KL, Matchar DB, Reichert TA: Regression models for prognostic prediction: advantages, problems and suggested solutions. Cancer Treat Rep 69:1071-7, 1985.
32. Haag K, Lu S, Rössle M, et al: The influence of TIPS on portal hemodynamics and liver function with respect to hepatic encephalopathy and survival. Hepatology 22:296A, 1995.
33. Casado M, Garcia Pagan JC, Banares R, et al: Clinical events following TIPS: correlation with hemodynamic findings. Hepatology 22:296A, 1995.
34. Audet RM, Themen G, Butterworth RF: Portacaval anastomosis results in more widespread changes in CNS metabolism and function in old adult versus young adult rats: implication for the pathogenesis of post-TIPS encephalopathy. Hepatology 22:160A, 1995.
35. Conjeevaram HS, Mullen KD, May ES, McCullough AJ: Gender-dependent reduction of spontaneous motor activity and growth in rats subjected to portacaval shunt. Hepatology 19:381-8, 1994.
36. Blei A: Hepatic encephalopathy in the age of TIPS. Hepatology 20:249-51, 1994.
37. Mullen KD: Hepatic encephalopathy after porto systemic shunts: any clues from TIPS? Am J Gastroenterol 90:531-3, 1995.
38. Fenyves D, Dufresne MP, Raymond J, et al: Successful reversal of chronic incapacitating post-TIPS encephalopathy by balloon occlusion of the stent. Can J Gastroenterol 8:75-80, 1994.
39. Haskal ZJ, Cope C, Soulen MC, et al: Intentional reversible thrombosis of transjugular intrahepatic portosystemic shunts. Radiology 195:485-8, 1995.
40. Hauenstein KH, Haag K, Ochs A, et al: The reducing stent treatment for transjugular intrahepatic portosystemic shunt-induced refractory hepatic encephalopathy and liver failure. Radiology 194:175-9, 1995.
41. Haskal ZJ, Middlebrook MR: Creation of a stenotic stent to reduce flow through a transjugular intrahepatic portosystemic shunt. J Vasc Intervent Radiol 5:827-30, 1994.